AI-designed GLP-1 peptides (IPA)

N/A

Report date: 2026/05/11 20:01:57

Base Information

Drug NameAI-designed GLP-1 peptides (IPA)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunoPrecise Antibodies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunoPrecise Antibodies Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A